MedTrace Logo

CINtec PLUS Triage in HPV Primary Screening

NCT03721484 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9800

Last updated 2018-10-26

No results posted yet for this study

Summary

Prospective study which will recruit participants when they attend for a routine cervical screening. The study will evaluate the use of CINtec PLUS for triage of human papillomavirus (HPV) positive participants in HPV primary screening.

Conditions

Interventions

DIAGNOSTIC_TEST

CINtec PLUS

CINtec PLUS testing will be used to triage HPV positive women to colposcopy

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Western Health and Social Care Trust

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2020-07-31
Completion
2021-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03721484 on ClinicalTrials.gov